Ilias Karaiskos (I Karaiskos)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 25

Top Venues

The Journal of antimicrobial chemotherapy

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Hygeia Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hygeia Hospital Mar 08 2010

Greece

ID spesialist :: 1st Department of Internal Medicine - Infectious Diseases

Publications

Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Helen Giamarellou, Lamprini Galani, Theodoros Karavasilis, Konstantinos Ioannidis, Ilias Karaiskos
Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics (Basel, Switzerland) 12 (10) (2023)
Daniele Roberto Giacobbe, Vincenzo di Pilato, Ilias Karaiskos, Tommaso Giani, Anna Marchese, Gian Maria Rossolini, Matteo Bassetti
Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Annals of medicine 55 (1) (2023)
Ilias Karaiskos, Aikaterini Gkoufa, Elena Polyzou, Georgios Schinas, Zoe Athanassa, Karolina Akinosoglou
High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms 11 (6) (2023)
Daniele Roberto Giacobbe, Vincenzo di Pilato, Ilias Karaiskos, Tommaso Giani, Anna Marchese, Gian Maria Rossolini, Matteo Bassetti
Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Annals of medicine 55 (1) (2023)
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Daniele Roberto Giacobbe, Vincenzo di Pilato, Ilias Karaiskos, Tommaso Giani, Anna Marchese, Gian Maria Rossolini, Matteo Bassetti
Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Annals of medicine 55 (1) (2023)
Ilias Karaiskos, Aikaterini Gkoufa, Elena Polyzou, Georgios Schinas, Zoe Athanassa, Karolina Akinosoglou
High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Microorganisms 11 (6) (2023)
Helen Giamarellou, Ilias Karaiskos
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Irene Galani, Ilias Karaiskos, Helen Giamarellou
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations. Expert review of anti-infective therapy 19 (11) (2021)
Daniele Roberto Giacobbe, Ilias Karaiskos, Matteo Bassetti
How do we optimize the prescribing of intravenous polymyxins to increase their longevity and efficacy in critically ill patients? Expert opinion on pharmacotherapy (2021)
Daniele Roberto Giacobbe, Andrea Cortegiani, Ilias Karaiskos, Toine Mercier, Sofia Tejada, Maddalena Peghin, Cecilia Grecchi, Chiara Rebuffi, Erika Asperges, Valentina Zuccaro, Luigia Scudeller, Matteo Bassetti, null null
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis. Journal of fungi (Basel, Switzerland) 7 (3) (2021)
Ilias Karaiskos, Irene Galani, Vassiliki Papoutsaki, Lamprini Galani, Helen Giamarellou
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies. Expert review of anti-infective therapy (2021)
Ilias Karaiskos, Helen Giamarellou
Carbapenem-Sparing Strategies for ESBL Producers: When and How. Antibiotics (Basel, Switzerland) 9 (2) (2020)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)
Irene Galani, Ilias Karaiskos, Evdokia Angelidis, Vassiliki Papoutsaki, Lamprini Galani, Maria Souli, Anastasia Antoniadou, Helen Giamarellou
Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (1) (2020)
Daniele Roberto Giacobbe, Ilias Karaiskos
Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 9 (4) (2020)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)
Ilias Karaiskos, Irene Galani, Maria Souli, Helen Giamarellou
Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert opinion on drug metabolism & toxicology 15 (2) (2019)
Ilias Karaiskos, Anastasia Antoniadou, Helen Giamarellou
Combination therapy for extensively-drug resistant gram-negative bacteria. Expert review of anti-infective therapy 15 (12) (2017)
Ilias Karaiskos, Lena E Friberg, Konstantinos Pontikis, Konstantinos Ioannidis, Vasiliki Tsagkari, Lamprini Galani, Eirini Kostakou, Fotini Baziaka, Charalambos Paskalis, Antonia Koutsoukou, Helen Giamarellou
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. Antimicrobial agents and chemotherapy 59 (12) (2015)

Ilias Karaiskos.css-eqlu8i{font-size:small;padding-left:4px;} (I Karaiskos)

Publication Activity (10 Years)

Top Topics

Top Venues

Ilias Karaiskos (I Karaiskos)